TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›MCS
MCS logo

MCS

MARCUS CORP

Next earnings Jul 30, 2026 · consensus $0.31 EPS, $214M rev

Last earnings -7.2% on 2026-04-30

Hold
$23.20
▼ -2.23%
$23.20▲ +39.69%
over 1Y
L $12.87H $24.89
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-2.2%
1W-0.9%
1M+16.3%
3M+30.5%
YTD+53.6%
1Y+39.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Fair value
Filings
Clean
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 9 analysts
Buy

Cheap small-cap theatre/hotel operator finally posting positive earnings, but thin margins, secular film risk and capex-heavy model cap the upside.

Revenue $758M · FY2025

Marcus Corp is a dual-segment operator (movie theatres + hotels/resorts) that has clawed back to modest profitability after a brutal post-COVID stretch. FY2025 revenue of $758M (+3.1% YoY) and net income of $12.7M (vs. -$7.79M in FY2024) mark a real inflection, but the five-year P&L is jagged: losses in FY2021 (-$43.3M), FY2022 (-$12.0M) and FY2024 (-$7.79M), with only FY2023 and FY2025 in the black. Net margin of 1.7% and operating margin of 2.2% leave essentially no cushion — a single bad film slate or weak hotel quarter flips this back to a loss. ROE of 2.8% is well below cost of capital.

The 10-K Risk Factors are unusually candid about the structural problem: management explicitly flags that 'the lack of both the quantity and audience appeal of motion pictures may adversely affect our financial results,' citing the WGA/SAG-AFTRA strikes that dented FY2023–FY2024 release volumes and warning that studios increasingly route films 'straight to streaming services.' Theatres also took a $5.2M impairment in FY2025 per the auditor's critical audit matter — small in dollars but a tell that individual theatre-level economics are deteriorating. The pandemic risk language is also more than boilerplate: management warns a future outbreak could threaten debt-covenant compliance, and balance-sheet liquidity is thin (cash $23.4M, down 42.6%; current assets $64.6M vs. current liabilities $163M — a current ratio of ~0.40).

Is MCS a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~23.20
  • Short call 24.5 @ ~1.10 est
debit $2,210max +$240max −$2,209BE 22.10

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$458M$677M$730M$736M$758M
Gross profit—————
Operating income-$41.5M$8.31M$33.9M$16.2M$17.1M
Net income-$43.3M-$12.0M$14.8M-$7.79M$12.7M
Diluted EPS—————
Net margin-9.4%-1.8%2.0%-1.1%1.7%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$848M
EV / EBITDA9.7
EV / Sales1.1
EV / FCF857.9
P / FCF720.8
PEG (trailing)—
Earnings yield1.8%
FCF yield0.1%

Quality & risk

ROIC (est.)2.2%
Free cash flow$989K
Total debt$159M
Net cash-$136M
Piotroski F-Score6/8

Capital returns

Buyback yield0.1%
Dividend yield (est.)1.3%
Shareholder yield1.4%
Shares Δ YoY-2.3%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has been improving.
  1. 8-K Shareholder vote2026-05-29

    Annual meeting vote results disclosed; routine governance outcome.

  2. 8-K Officer / director change2026-04-30

    Q1 FY2026 quarterly report filed; ongoing post-recovery operations.

  3. 8-K Earnings results2026-04-30

    Q1 FY2026 quarterly report filed; ongoing post-recovery operations.

  4. 10-Q Quarterly report2026-04-30

    Q1 FY2026 quarterly report filed; ongoing post-recovery operations.

  5. DEF 14A Proxy statement2026-04-07

    Proxy: director slate, exec comp and routine annual-meeting matters.

  6. 10-K Annual report2026-02-27

    FY25 swings to $12.7M profit; $5.2M theatre impairment, debt up 6.7%.

  7. 8-K Earnings results2026-02-26

    FY2025 earnings: net income $12.7M vs prior loss, revenue +3% to $758M.

  8. 8-K Officer / director change2025-11-12

    Officer/director change announced; leadership update.

  9. 8-K Earnings results2025-10-31

    Q3 FY2025 quarterly report filed.

Recent filings

all on EDGAR ↗
4Period ending 2026-06-252026-06-29open ↗8-KPeriod ending 2026-05-212026-05-29open ↗4/APeriod ending 2026-05-212026-05-27open ↗4/APeriod ending 2026-05-212026-05-27open ↗4/APeriod ending 2026-05-212026-05-27open ↗4/APeriod ending 2026-05-212026-05-27open ↗4/APeriod ending 2026-05-212026-05-27open ↗4/APeriod ending 2026-05-212026-05-27open ↗4Period ending 2026-05-212026-05-26open ↗4Period ending 2026-05-212026-05-26open ↗4Period ending 2026-05-212026-05-26open ↗4Period ending 2026-05-212026-05-26open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueA+
GrowthB+
ProfitabilityD
Financial healthA-
MomentumB+
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
12.8752-week24.89
Revenue
$758M
+3.1% YoY
Net margin
1.7%
ROE
2.8%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$758M+3.1%
Net income$12.7M+263.0%
Operating income$17.1M+5.5%
Cash & equivalents$23.4M-42.6%
Total assets$1.01B-2.9%
Stockholders' equity$457M-1.6%
Op.: 2.2%

Frequently asked

Is MARCUS CORP (MCS) a buy?
MCS currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Cheap small-cap theatre/hotel operator finally posting positive earnings, but thin margins, secular film risk and capex-heavy model cap the upside.
What is MARCUS CORP's quality score?
MCS scores 73.33869151919157/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0000062234, latest 10-Q filed 2026-04-30) · EODHD · Proprietary analysis · as of 6/25/2026, 3:15:33 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 25, 2026, 11:15 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-06-25
KISSINGER THOMAS F
Sr Exec VP, Gen Counsel & Secy
Exercise50.0K @ $17.04$852K
2026-06-25
KISSINGER THOMAS F
Sr Exec VP, Gen Counsel & Secy
Tax41.7K @ $23.37$975K
2026-05-21
Gehl Katherine M.
Director
Award1.39K @ $17.97$25.0K
2026-05-21
STARK BRIAN JAY
Director
Award1.39K @ $17.97$25.0K
2026-05-21
SELIG ALLAN H
Director
Award1.39K @ $17.97$25.0K
2026-05-21
Ramirez Austin M
Director
Award1.39K @ $17.97$25.0K
2026-05-21
OLSON BRUCE J
Director
Award1.39K @ $17.97$25.0K
2026-05-21
MILSTEIN PHILIP L
Director
Award1.39K @ $17.97$25.0K
2026-05-21
Leff Paul Adam
Director
Award1.39K @ $17.97$25.0K

Dividends

Quarterly
Yield (TTM)
1.4%
Annual / share
$0.32
Last ex-date
2026-06-01
Last amount
$0.08
ex 2026-06-01paid 2026-06-15$0.08
ex 2026-02-25paid 2026-03-16$0.08
ex 2025-11-25paid 2025-12-15$0.08
ex 2025-08-25paid 2025-09-15$0.08
ex 2025-05-27paid 2025-06-16$0.07
ex 2025-02-25paid 2025-03-17$0.07

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-04-30Beat +5.2% est▼ -7.17%8-K ↗
2026-02-26Beat +199.7% est▲ +3.40%8-K ↗
2025-10-31Beat +1.2% est▲ +8.84%8-K ↗
2025-08-01Beat +15.3% est▼ -9.16%8-K ↗
2025-05-06—▼ -1.28%8-K ↗
2025-02-27—▼ -11.16%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

Disclosed under the STOCK Act

2021-04-05Ashley Hinson ArenholzSell$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score73 vs 67
Revenue growth3.1% vs 7.5%
Net margin1.7% vs 10.0%
Return on equity2.8% vs 12.0%
P/E— vs 26.2

News sentiment

EODHD · 5d
Bullish
+0.08
vs typical · 5 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.